BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31434075)

  • 1. Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
    Jiang H; Li C; Liu Z; Shengjing Hospital ;
    Acta Haematol; 2020; 143(1):51-59. PubMed ID: 31434075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.
    Rassidakis GZ; Herold N; Myrberg IH; Tsesmetzis N; Rudd SG; Henter JI; Schaller T; Ng SB; Chng WJ; Yan B; Ng CH; Ravandi F; Andreeff M; Kantarjian HM; Medeiros LJ; Xagoraris I; Khoury JD
    Blood Cancer J; 2018 Oct; 8(11):98. PubMed ID: 30341277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
    Chen S; Dai Y; Harada H; Dent P; Grant S
    Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of anti-leukemic activity of the Bcl-2 homology domain-3 mimetic S1.
    Liu Y; Li Z; Song T; Xue Z; Zhang Z
    Biomed Pharmacother; 2013 Sep; 67(7):583-91. PubMed ID: 23706691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak.
    Kremer KN; Peterson KL; Schneider PA; Meng XW; Dai H; Hess AD; Smith BD; Rodriguez-Ramirez C; Karp JE; Kaufmann SH; Hedin KE
    J Biol Chem; 2013 Aug; 288(32):22899-914. PubMed ID: 23798675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
    Schneider C; Oellerich T; Baldauf HM; Schwarz SM; Thomas D; Flick R; Bohnenberger H; Kaderali L; Stegmann L; Cremer A; Martin M; Lohmeyer J; Michaelis M; Hornung V; Schliemann C; Berdel WE; Hartmann W; Wardelmann E; Comoglio F; Hansmann ML; Yakunin AF; Geisslinger G; Ströbel P; Ferreirós N; Serve H; Keppler OT; Cinatl J
    Nat Med; 2017 Feb; 23(2):250-255. PubMed ID: 27991919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
    Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CB; Heshmati Y; Hagenkort A; Kutzner J; Page BD; Calderón-Montaño JM; Loseva O; Jemth AS; Bulli L; Axelsson H; Tesi B; Valerie NC; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter JI; Helleday T; Schaller T
    Nat Med; 2017 Feb; 23(2):256-263. PubMed ID: 28067901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed apoptosis by neutrophils from COPD patients is associated with altered Bak, Bcl-xl, and Mcl-1 mRNA expression.
    Zhang J; He J; Xia J; Chen Z; Chen X
    Diagn Pathol; 2012 Jun; 7():65. PubMed ID: 22686245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.
    Kodigepalli KM; Bonifati S; Tirumuru N; Wu L
    Cell Cycle; 2018; 17(9):1124-1137. PubMed ID: 29911928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
    Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
    Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the lifespan in dendritic cell subsets.
    Chen M; Huang L; Shabier Z; Wang J
    Mol Immunol; 2007 Apr; 44(10):2558-65. PubMed ID: 17267035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
    Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
    Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane.
    O'Neill KL; Huang K; Zhang J; Chen Y; Luo X
    Genes Dev; 2016 Apr; 30(8):973-88. PubMed ID: 27056669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors.
    Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kamocki Z; Zaręba K; Kemona A; Kędra B
    Adv Med Sci; 2012 Jun; 57(1):77-83. PubMed ID: 22440942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.
    Kodigepalli KM; Li M; Bonifati S; Panfil AR; Green PL; Liu SL; Wu L
    Cell Cycle; 2018; 17(23):2564-2576. PubMed ID: 30474474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-x(L).
    Lindenboim L; Blacher E; Borner C; Stein R
    Cell Death Differ; 2010 Feb; 17(2):346-59. PubMed ID: 19816507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.